Overview
Announcements

Ordinary Rebalance | Solactive Global Healthcare 20 Index | Effective Date 24th July 2023

In the ordinary rebalance, the following composition will be implemented effective open 24.07.2023:

ABBOTT LABORATORIES
ABBVIE INC
AMGEN INC
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO
DANAHER CORP
ELI LILLY & CO
GILEAD SCIENCES INC
INTUITIVE SURGICAL INC
JOHNSON & JOHNSON
MEDTRONIC PLC
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
ROCHE HOLDING AG
SANOFI SA
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
VERTEX PHARMACEUTICALS INC